Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Capital Expenditures (2016 - 2025)

Cumberland Pharmaceuticals' Capital Expenditures history spans 16 years, with the latest figure at -$1.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 100.04% to -$1.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $97903.0, a 47.31% increase, with the full-year FY2025 number at $97903.0, up 47.31% from a year prior.
  • Capital Expenditures hit -$1.0 in Q4 2025 for Cumberland Pharmaceuticals, down from $23788.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for CPIX hit a ceiling of $137255.0 in Q2 2022 and a floor of -$153528.0 in Q4 2022.
  • Historically, Capital Expenditures has averaged $32565.6 across 5 years, with a median of $26736.0 in 2022.
  • The widest YoY moves for Capital Expenditures: up 810.6% in 2022, down 1797.0% in 2022.
  • Tracing CPIX's Capital Expenditures over 5 years: stood at $9047.0 in 2021, then tumbled by 1797.0% to -$153528.0 in 2022, then skyrocketed by 131.7% to $48673.0 in 2023, then plummeted by 95.31% to $2283.0 in 2024, then tumbled by 100.04% to -$1.0 in 2025.
  • Business Quant data shows Capital Expenditures for CPIX at -$1.0 in Q4 2025, $23788.0 in Q3 2025, and $26486.0 in Q2 2025.